Home/Filings/4/0001415889-24-011043
4//SEC Filing

Stanton Matthew 4

Accession 0001415889-24-011043

CIK 0001733294other

Filed

Apr 16, 8:00 PM ET

Accepted

Apr 17, 5:10 PM ET

Size

8.6 KB

Accession

0001415889-24-011043

Insider Transaction Report

Form 4
Period: 2024-04-15
Stanton Matthew
CHIEF SCIENTIFIC OFFICER
Transactions
  • Exercise/Conversion

    Common Stock

    2024-04-15+1,674245,447 total
  • Tax Payment

    Common Stock

    2024-04-15$3.70/sh492$1,820244,955 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-04-151,67418,407 total
    Common Stock (1,674 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents the right to receive one share of the company's common stock.
  • [F2]On January 20, 2023, the reporting person was granted 26,775 restricted stock units. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter.

Issuer

Generation Bio Co.

CIK 0001733294

Entity typeother

Related Parties

1
  • filerCIK 0001814198

Filing Metadata

Form type
4
Filed
Apr 16, 8:00 PM ET
Accepted
Apr 17, 5:10 PM ET
Size
8.6 KB